Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat

Psychopharmacology

Volumn 213, Issue 2-3, 2011, Pages 377-391

  Ádori, Csaba ^a   Low, Péter ^b   Andó, Rómeó D ^a,c   Gutknecht, Lise ^d   Pap, Dorottya ^a   Truszka, Ferencné ^a   Takács, József ^e   Kovács, Gábor G ^f   Lesch, Klaus Peter ^d   Bagdy, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA, "Ecstasy"); Degeneration; Microtubule; Morphometry; Pre embedding immunoelectron microscopy; Serotonin (5 HT); Tryptophan hydroxylase 2 (Tph2)

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN VEIN; CELL ORGANELLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DORSAL RAPHE NUCLEUS; ENZYME SPECIFICITY; FRONTAL CORTEX; MALE; MICROTUBULE; MITOCHONDRIAL MEMBRANE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE FIBER; NEURITE; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE; SEROTONINERGIC NERVE CELL; STRUCTURE ANALYSIS; VARICOSIS;

ANIMALS; AXONS; FRONTAL LOBE; MALE; MICROSCOPY, ELECTRON; MICROSCOPY, IMMUNOELECTRON; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEURITES; RAPHE NUCLEI; RATS; SEROTONIN; SEROTONIN AGENTS; TRYPTOPHAN HYDROXYLASE;

EID: 79952487750     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2041-2     Document Type: Article

References (66)

1. Adori C, Ando RD, Kovacs GG, Bagdy G (2006) Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J Comp Neurol 497:251-269 (Pubitemid 43825430)
2. Aguirre N, Barrionuevo M, Ramirez MJ, Del Rio J, Lasheras B (1999) Alpha-lipoic acid prevents 3, 4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. NeuroReport 10:3675-3680
3. Ando RD, Adori C, Kirilly E, Molnar E, Kovacs GG, Ferrington L, Kelly PA, Bagdy G (2010) Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion. Behav Brain Res 207:280-289
4. Arai R, Karasawa N, Kurokawa K, Kanai H, Horiike K, Ito A (2002) Differential subcellular location of mitochondria in rat serotonergic neurons depends on the presence and the absence of monoamine oxidase type B. Neuroscience 114:825-835
5. Baas PW, Qiang L (2005) Neuronal microtubules: when the MAP is the roadblock. Trends Cell Biol 15:183-187 (Pubitemid 40487519)
6. Baker KG, Halliday GM, Tork I (1990) Cytoarchitecture of the human dorsal raphe nucleus. J Comp Neurol 301:147-161 (Pubitemid 20370470)
7. Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G (2004) Effects of a single dose of 3, 4- methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology (Berl) 173:296-309 (Pubitemid 38703803)
8. Battaglia G, Yeh SY, De Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274 (Pubitemid 19258259)
9. Bellomo G, Mirabelli F, Vairetti M, Iosi F, Malorni W (1990) Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocyto-chemical features. J Cell Physiol 143:118-128
10. Bendotti C, Baldessari S, Pende M, Tarizzo G, Miari A, Presti ML, Mennini T, Samanin R (1994) Does GFAP mRNA and mitochondrial benzodiazepine receptor binding detect serotonergic neuronal degeneration in rat? Brain Res Bull 34:389-394
11. Beveridge TJ, Mechan AO, Sprakes M, Pei Q, Zetterstrom TS, Green AR, Elliott JM (2004) Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain. Psychopharmacology (Berl) 173:346-352 (Pubitemid 38703808)
12. Biezonski DK, Meyer JS (2010) Effects of 3, 4- methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J Neurochem 112:951-962
13. Bonkale WL, Austin MC (2008) 3, 4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus. Neuroscience 155:270-276
14. Callahan BT, Cord BJ, Ricaurte GA (2001) Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. Synapse 40:113-121
15. Capela JP, Carmo H, Remiao F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210-271
16. Chou SM, Hartmann HA (1964) Axonal lesions and waltzing syndrome after Idpn administration in rats. With a concept -"Axostasis". Acta Neuropathol 3:428-450
17. Cohen Z, Ehret M, Maitre M, Hamel E (1995) Ultrastructural analysis of tryptophan hydroxylase immunoreactive nerve terminals in the rat cerebral cortex and hippocampus: their associations with local blood vessels. Neuroscience 66:555-569
18. de la Torre R, Farre M (2004) Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 25:505-508
19. De Repentigny Y, Deschenes-Furry J, Jasmin BJ, Kothary R (2003) Impaired fast axonal transport in neurons of the sciatic nerves from dystonia musculorum mice. J Neurochem 86:564-571 (Pubitemid 36897437)
20. Fader CM, Colombo MI (2009) Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 16:70-78
21. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3, 4- methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurosci 15:5476-5485
22. Fornai F, Lenzi P, Frenzilli G, Gesi M, Ferrucci M, Lazzeri G, Biagioni F, Nigro M, Falleni A, Giusiani M, Pellegrini A, Blandini F, Ruggieri S, Paparelli A (2004) DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy). Psychopharmacology (Berl) 173:353-363 (Pubitemid 38703809)
23. Fornai F, Soldani P, Lazzeri G, di Poggio AB, Biagioni F, Fulceri F, Batini S, Ruggieri S, Paparelli A (2005) Neuronal inclusions in degenerative disorders do they represent static features or a key to understand the dynamics of the disease? Brain Res Bull 65:275-290
24. Graham D, Lantos P (2002) Greenfield's neuropathology. Arnold publisher, London
25. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508 (Pubitemid 37013213)
26. Gutknecht L, Waider J, Kraft S, Kriegebaum C, Holtmann B, Reif A, Schmitt A, Lesch KP (2008) Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm 115:1127-1132
27. Gutknecht L, Kriegebaum C, Waider J, Schmitt A, Lesch KP (2009) Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 19:266-282
28. Holzel B, Pfister C (1981) Topography and cytoarchitecture of the raphe nuclei in the rat. J Hirnforsch 22:697-708 (Pubitemid 12048502)
29. Joh TH, Shikimi T, Pickel VM, Reis DJ (1975) Brain tryptophan hydroxylase: purification of, production of antibodies to, and cellular and ultrastructural localization in serotonergic neurons of rat midbrain. Proc Natl Acad Sci USA 72:3575-3579
30. Kirilly E, Molnar E, Balogh B, Kantor S, Hansson SR, Palkovits M, Bagdy G (2008) Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days. Int J Neuropsychopharmacol 11:795-809
31. Kivell B, Day D, Bosch P, Schenk S, Miller J (2010) MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Neuroscience 168:82-95
32. Kovacs GG, Ando RD, Adori C, Kirilly E, Benedek A, Palkovits M, Bagdy G (2007) Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord. Neuropathol Appl Neurobiol 33:193-203 (Pubitemid 46385713)
33. Linder JC, Young SJ, Groves PM (1995) Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem Int 26:195-202
34. Liposits Z, Gorcs T, Trombitas K (1985) Ultrastructural analysis of central serotoninergic neurons immunolabeled by silver-gold-intensified diaminobenzidine chromogen. Completion of immunocytochemistry with X-ray microanalysis. J Histochem Cytochem 33:604-610 (Pubitemid 15029594)
35. Malek ZS, Dardente H, Pevet P, Raison S (2005) Tissue-specific expression of tryptophan hydroxylase mRNAs in the rat midbrain: anatomical evidence and daily profiles. Eur J Neurosci 22:895-901 (Pubitemid 41243329)
36. Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F (1999) Acute toxicity of 3, 4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats. Pharmacol Biochem Behav 64:29-34 (Pubitemid 29415793)
37. Marques SA, Taffarel M, Blanco Martinez AM (2003) Participation of neurofilament proteins in axonal dark degeneration of rat's optic nerves. Brain Res 969:1-13 (Pubitemid 36369607)
38. Medana IM, Esiri MM (2003) Axonal damage: a key predictor of outcome in human CNS diseases. Brain 126:515-530 (Pubitemid 36240854)
39. Meyer JS, Piper BJ, Vancollie VE (2008) Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence. Ann NY Acad Sci 1139:151-163
40. Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann NY Acad Sci 600:649-661, discussion 661-4
41. Mori S, Matsuura T, Takino T, Sano Y (1987) Light and electron microscopic immunohistochemical studies of serotonin nerve fibers in the substantia nigra of the rat, cat and monkey. Anat Embryol (Berl) 176:13-18
42. Morshedi MM, Rademacher DJ, Meredith GE (2009) Increased synapses in the medial prefrontal cortex are associated with repeated amphetamine administration. Synapse 63:126-135
43. Narciso MS, Hokoc JN, Martinez AM (2001) Watery and dark axons in Wallerian degeneration of the opossum's optic nerve: different patterns of cytoskeletal breakdown? An Acad Bras Cienc 73:231-243
44. Nixon RA, Cataldo AM (1995) The endosomal-lysosomal system of neurons: new roles. Trends Neurosci 18:489-496
45. O'Callaghan JP, Miller DB (1993) Quantification of reactive gliosis as an approach to neurotoxicity assessment. NIDA Res Monogr 136:188-212
46. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylene-dioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803
47. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926 (Pubitemid 28375758)
48. Orio L, O'Shea E, Sanchez V, Pradillo JM, Escobedo I, Camarero J, Moro MA, Green AR, Colado MI (2004) 3, 4-Methylene-dioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J Neurochem 89:1445-1453 (Pubitemid 38802666)
49. WC PG (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press Inc., New York
50. Pickel VM, Joh TH, Reis DJ (1976) Monoamine-synthesizing enzymes in central dopaminergic, noradrenergic and serotonergic neurons. Immunocytochemical localization by light and electron microscopy. J Histochem Cytochem 24:792-306
51. Puerta E, Hervias I, Aguirre N (2009) On the mechanisms underlying 3, 4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg. Neuropsychobiology 60:119-129
52. Quate L, McBean DE, Ritchie IM, Olverman HJ, Kelly PA (2004) Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat. Psychopharmacology (Berl) 173:287-295 (Pubitemid 38703802)
53. Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW (1988) (+/-)3, 4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in non-human primates. JAMA 260:51-55
54. Rowland NE, Kalehua AN, Li BH, Semple-Rowland SL, Streit WJ (1993) Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions. Brain Res 624:35-43 (Pubitemid 23281799)
55. Ryan LJ, Linder JC, Martone ME, Groves PM (1990) Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res 518:67-77 (Pubitemid 20197032)
56. Sahenk Z, Mendell JR (1983) Studies on the morphologic alterations of axonal membraneous organelles in neurofilamentous neuropathies. Brain Res 268:239-247 (Pubitemid 13096593)
57. Sharma HS, Kiyatkin EA (2009) Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. J Chem Neuroanat 37:18-32
58. Smiley JF, Goldman-Rakic PS (1996) Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy. J Comp Neurol 367:431-443 (Pubitemid 26107129)
59. Spencer PS, Schaumburg HH (1975) Nervous system dying-back disease produced by 2, 5-hexanedione. Trans Am Neurol Assoc 100:148-151
60. Tanner KD, Levine JD, Topp KS (1998) Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol 395:481-492 (Pubitemid 28226093)
61. Tork I (1990) Anatomy of the serotonergic system. Ann NY Acad Sci 600:9-34, discussion 34-5
62. Vorhees CV, Morford LL, Inman SL, Reed TM, Schilling MA, Cappon GD, Moran MS, Nebert DW (1999) Genetic differences in spatial learning between Dark Agouti and Sprague-Dawley strains: possible correlation with the CYP2D2 polymorphism in rats treated neonatally with methamphetamine. Pharmacogenetics 9:171-181 (Pubitemid 29358999)
63. Wang X, Baumann MH, Xu H, Rothman RB (2004) 3, 4- methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53:240-248 (Pubitemid 39045543)
64. Wang X, Baumann MH, Dersch CM, Rothman RB (2007) Restoration of 3, 4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan. Neuroscience 148:212-220 (Pubitemid 47211624)
65. Weissmann D, Belin MF, Aguera M, Meunier C, Maitre M, Cash CD, Ehret M, Mandel P, Pujol JF (1987) Immunohistochemistry of tryptophan hydroxylase in the rat brain. Neuroscience 23:291-304 (Pubitemid 17159573)
66. Welt K, Weiss J, Martin R, Dettmer D, Hermsdorf T, Asayama K, Meister S, Fitzl G (2004) Ultrastructural, immunohistochemical and biochemical investigations of the rat liver exposed to experimental diabetes und acute hypoxia with and without application of Ginkgo extract. Exp Toxicol Pathol 55:331-345 (Pubitemid 38419707)